Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation

Basit Öğe Kaydı
dc.contributor.authorUguz, Faruk
dc.date.accessioned2024-02-23T14:20:56Z
dc.date.available2024-02-23T14:20:56Z
dc.date.issued2019
dc.departmentNEÜen_US
dc.description.abstractSelective serotonin reuptake inhibitors (SSRIs), especially sertraline and paroxetine, are first-line antidepressants in the treatment of postpartum depression in breastfeeding women as these drugs are well tolerated by most breastfed infants. Although some women with these diagnoses require additional antidepressants to SSRIs, the safety of combined usage of SSRIs and mirtazapine is currently unknown. This report includes short-term safety data of breastfed infants exposed to paroxetine plus low-dose mirtazapine.en_US
dc.identifier.doi10.1089/bfm.2018.0197
dc.identifier.endpage132en_US
dc.identifier.issn1556-8253
dc.identifier.issn1556-8342
dc.identifier.issue2en_US
dc.identifier.pmid30489153en_US
dc.identifier.scopus2-s2.0-85062818193en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage131en_US
dc.identifier.urihttps://doi.org/10.1089/bfm.2018.0197
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13351
dc.identifier.volume14en_US
dc.identifier.wosWOS:000451528300001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofBreastfeeding Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLactationen_US
dc.subjectBreastfeedingen_US
dc.subjectAntidepressantsen_US
dc.titleShort-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu